Disease Control Priorities in Rheumatoid Arthritis (RA)

Want to establish a clearer picture on Disease Control Priorities in Rheumatoid Arthritis (RA)?

Listen to Professor Jonathan Kay (M.D. Director of Clinical Research, Rheumatology, professor of Medicine University of Massachusetts Medical School, UMass Memorial Medical Center, USA) speak about the comparison between Anti MCV (Mutated Citrullinated Vimetin) and Anti CCP (Cyclic Citrullinated protein) in diagnosis and management of RA, along with comparing Methotrexate and Tumour Necrosis Factor inhibitor to O’Dell’s ‘Triple Theory’.